FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs
This
week, PharmaCompass brings you key highlights of the US Food and Drug Administration’s D
FDA okays 50 new drugs in 2024; BMS’ Cobenfy, Lilly’s Kisunla lead pack of breakthrough therapies
In 2024, the biopharma industry continued to advance on its robust trajectory of innovation. Though

Market Place
Sourcing Support